1. Introduction
1.1
1.2
2. Objectives
2.1
2.2
(b)
(c)
3. Authority
3.1
3.2
The Medicine Advertisements Board reserves the right to delete from any
advertisements, acts which could bring about undesirable thoughts and
impression to the viewers.
3.3
Changes to the Guidelines may be made from time to time by the Medicine
Advertisements Board without giving prior notice.
Page 1 of 1
4. Prohibitions
4.1
Advertisements should not refer to any article or articles in terms which are
calculated to lead to the use of that article or articles for the purpose of:(a)
4.2
b)
c)
d)
5. Contents of Advertisements
Advertisements should contain information that is reliable, accurate, truthful,
informative, balanced, up-to-date, capable of substantiation and in good taste.
They should not contain any misleading or unverifiable statement or omissions
likely to induce medically unjustifiable use or to give rise to undue risks.
Page 2 of 2
(b)
(b)
(c)
(d)
directly
or
by
implication
exploit
requirement/beliefs of any community.
the
religious
Page 3 of 3
(b)
Misleading Statement
Advertisements should not contain any statement, or visual presentation
which, directly or by implication, omission, ambiguity or claim, is likely to
mislead the consumer about any product or advertiser, in particular with
regards to:
5.3
(a)
(b)
Substantiation
All descriptions, claims and comparisons which relate to matters of
objectively ascertainable facts should be capable of substantiation and
should be held ready for immediate production upon request to the Medicine
Advertisements Board
5.4
Page 4 of 4
(b)
5.5
Testimonials
No advertisement for a product may include a testimonial:
5.6
5.7
(a)
(b)
(b)
(c)
General Claims
5.7.1. Hyperbole
Hyperbole should not be used in Medicine Advertisements unless
such hyperbole is used to attract attention to the advertisement and
is not used or implied in the advertisement as a claim or inference to
the superiority or superlative status of the product advertised.
Advertisements should not:
(a)
Page 5 of 5
(b)
(c)
(d)
Specific Claims
5.8.1 Sexual weakness, Ageing, Loss of Virility
Advertisements should not suggest or imply that any product offered
will:
(a)
(b)
(c)
Page 6 of 6
(b)
Page 7 of 7
(b)
(c)
(d)
(e)
(f)
products for the relief of fever, cough and pain should include the
following statement
If symptoms persist, please consult your doctor
(g)
(h)
products for weight reduction / weight loss should include the following
statement:
This is a traditional preparation. Should be taken with a
balanced diet and regular exercise
(b)
(c)
Page 8 of 8
(d)
(b)
(c)
Others
6.1 Press release
(a) Allowed for launching of new chemical entities (NCE). Allowed once
only in newspapers. The launch can also be broadcasted. The
contents are as approved by the Medicine Advertisements Board.
(b) The contents for the press release of New Chemical Entity (NCE) are:
(i) indications as approved by Drug Control Authority (DCA)
(ii) cost per dose
(iii) list of reference journals
(c) Criteria for NCE are:
(i) new drugs
(ii)new combination of active pharmaceutical ingredients
(iii)available in Malaysia for the first time
(iv)new indication(s)
(Note: All products must be registered with DCA)
Page 9 of 9
Page 10 of 10